SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-191517
Filing Date
2020-07-13
Accepted
2020-07-13 07:41:37
Documents
1
Period of Report
2020-07-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d104522d8k.htm 8-K 21261
  Complete submission text file 0001193125-20-191517.txt   22311
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38886 | Film No.: 201024311
SIC: 2834 Pharmaceutical Preparations